Table 1.
Pregnancy and coronaviruses: a summary of published, peer-reviewed reports.
Characteristic | COVID-19 | SARS | MERS |
---|---|---|---|
Cases, n | 162 | 17 | 12 |
Age, y | 23–40 | 27–44 | 31–39 |
GA at infection | 150 at 36+ wk; 12 earlier | 4–32 | 4–38 |
Symptoms at presentation, % | |||
Fever | 50 | 100 | 58 |
Cough | 34 | 76 | 67 |
Dyspnea | 16 | 35 | 58 |
Investigations, % | |||
CXR/CT evidence of pneumonia | 85 | 100 | 100 |
Maternal complications, % | |||
Mortality | 2 | 18 | 25 |
Mechanical ventilation | 4 | 35 | 41 |
Fetal complications, % | |||
Miscarriage | 2 | 25 | 18 |
IUGR | 9 | 13 | 9 |
Preterm birth | 38 | 25 | 27 |
Neonatal complications, % | |||
Neonatal deaths | 2 | 0 | 9 |
Vertical transmission | Low vs. none | 0 | 0 |
Note: COVID-19 = coronavirus disease 2019; CT = computerized tomography; CXR = chest x-ray; GA = gestational age; IUGR = intrauterine growth restriction; MERS = Middle East respiratory syndrome; SARS = Severe Acute Respiratory Syndrome; GA = gestational age; IUGR = intrauterine growth restriction.
(Updated with more recent reports of COVID-19 cases, but otherwise from Dashraath P, Jing Lin Jeslyn W, Mei Xian Karen L, Li Min L, Sarah L, Biswas A, et al: Coronavirus Disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020 doi: https://doi.org/10.1016/j.ajog.2020.03.021.)